- Home
- IMNN vs CNEY Comparison
IMNN vs CNEY Comparison
Compare IMNN & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNN | CNEY |
|---|---|---|
| Founded | 1982 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 11.3M |
| IPO Year | 1985 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMNN | CNEY |
|---|---|---|
| Price | $3.55 | $0.61 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $182.61 | N/A |
| AVG Volume (30 Days) | 76.9K | ★ 1.4M |
| Earning Date | 02-26-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,049,275.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.99 | $0.31 |
| 52 Week High | $41.22 | $10.25 |
Technical Indicators
Market Signals| Indicator | IMNN | CNEY |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 44.79 |
| Support Level | $3.39 | $0.31 |
| Resistance Level | $3.77 | $0.80 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 29.27 | 62.29 |
Price Performance
Historical ComparisonAbout IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.